Clinical Trial Update: Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Shuxuening Injection as an adjunct to intravenous thrombolysis in acute ischemic stroke. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Shuxuening Injection

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Ischemic Stroke, Acute | Phase 3 | Status: RECRUITING